Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty

被引:18
|
作者
Lee, Joon Kyu [1 ,2 ]
Lee, Kee Byoung [3 ]
Kim, Joong Il [4 ]
Park, Gun Tae [5 ]
Cho, Young Chang [1 ]
机构
[1] Konkuk Univ, Med Ctr, Dept Orthopaed Surg, 120-1 Neungdong Ro, Seoul 05030, South Korea
[2] Konkuk Univ, Sch Med, Res Inst Med Sci, 120-1 Neungdong Ro, Seoul 05030, South Korea
[3] Cheongju St Marys Hosp, Dept Orthopaed Surg, 173-19 Jusung Ro, Cheongju 28323, Chungcheongbuk, South Korea
[4] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Orthopaed Surg, 1 Singil Ro, Seoul 07741, South Korea
[5] Hallym Univ, Dept Orthopaed Surg, Sacred Heart Hosp, 22 Gwanpyeong Ro, Anyang Si 14068, Gyeonggi Do, South Korea
关键词
Deep vein thrombosis; Total knee arthroplasty; Anticoagulant agent; Low-molecular-weight-heparin; Risk factor; MAJOR ORTHOPEDIC-SURGERY; TOTAL HIP-ARTHROPLASTY; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; GENERAL-ANESTHESIA; ASIAN PATIENTS; THROMBOPROPHYLAXIS; FONDAPARINUX; REPLACEMENT; ENOXAPARIN;
D O I
10.1186/s43019-021-00109-z
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background With an increase in deep vein thrombosis (DVT) following total knee arthroplasty (TKA) in the Asian population, most surgeons today use a form of prophylactic anticoagulant agents in patients after TKA. Nevertheless, DVT occasionally develops even in these patients with prophylaxis. The purpose of this study was to identify the risk factors for DVT after TKA in cases of postoperative low-molecular-weight heparin (LMWH) use. Methods We designed a retrospective study with 103 patients who underwent primary TKA. From the second postoperative day, 60 mg of LMWH was subcutaneously injected into the patients daily. On the seventh postoperative day, patients had computed tomography angiography to check whether they had DVT. Regarding risk factors, we investigated patients' gender, age, surgical site (unilateral/bilateral), body mass index, method of anesthesia, preoperative hypertension, diabetes, hypercholesterolemia status, and prothrombin time/international normalized ratio from electronic medical records. We analyzed the statistical significance of these risk factors. Results Statistically significant factors in the single-variable analysis were surgical site (unilateral/bilateral), body mass index, preoperative hypertension status, and anesthesia method. Multiple logistic regression analysis with these factors revealed that the surgical site (unilateral/bilateral, p = 0.024) and anesthesia method (p = 0.039) were significant factors for the occurrence of postoperative DVT after TKA. Conclusions Patients undergoing simultaneous bilateral TKAs and patients undergoing TKA with general anesthesia need more attention regarding DVT even with chemoprophylaxis using LMWH after TKA.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty
    Kim, Young-Hoo
    Yoo, Jeong-Hyun
    Kim, Jun-Shik
    JOURNAL OF ARTHROPLASTY, 2007, 22 (07): : 974 - 980
  • [32] Preoperative risk factors for deep vein thrombosis in knee osteoarthritis patients undergoing total knee arthroplasty
    Xiong, Xiaojuan
    Cheng, Bo
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2023, 28 (01) : 180 - 187
  • [33] Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement
    Bruno Detournay
    André Planes
    Nicole Vochelle
    Francis Fagnani
    PharmacoEconomics, 1998, 13 : 81 - 89
  • [34] Prevalence of Deep Vein Thrombosis and Pulmonary Embolism Treated with Mechanical Compression Device After Total Knee Arthroplasty in Asian Patients
    Kim, Young-Hoo
    Kulkarni, Sourabh S.
    Park, Jang-Won
    Kim, Jun-Shik
    JOURNAL OF ARTHROPLASTY, 2015, 30 (09): : 1633 - 1637
  • [35] Thrombosis Prevention After Total Hip Arthroplasty A Prospective, Randomized Trial Comparing a Mobile Compression Device with Low-Molecular-Weight Heparin
    Colwell, Clifford W., Jr.
    Froimson, Mark I.
    Mont, Michael A.
    Ritter, Merrill A.
    Trousdale, Robert T.
    Buchler, Knute C.
    Spitzer, Andrew
    Donaldson, Thomas K.
    Padgett, Douglas E.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2010, 92A (03): : 527 - 535
  • [36] Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients
    Chun-mei Wang
    Xiang-feng Guo
    Li-min Liu
    Ying Huang
    Liang Meng
    Li-po Song
    Ying-feng Wu
    Ya-chan Ning
    Kathleen H. Reilly
    Hai-bo Wang
    Chinese Journal of Integrative Medicine, 2022, 28 : 771 - 778
  • [37] Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study
    Tianxiang Yang
    Zige Liu
    Bowen Zhang
    Jinning Zhang
    Anning Ma
    Dede Cao
    Desheng Chen
    BMC Musculoskeletal Disorders, 24
  • [38] Comparison of the efficacy of low-molecular-weight heparin and fondaparinux sodium after total knee arthroplasty: a retrospective cohort study
    Yang, Tianxiang
    Liu, Zige
    Zhang, Bowen
    Zhang, Jinning
    Ma, Anning
    Cao, Dede
    Chen, Desheng
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [39] Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis
    Senzolo, Marco
    Piano, Salvatore
    Shalaby, Sarah
    Tonon, Marta
    Tonello, Silvia
    Zanetto, Alberto
    Sacerdoti, David
    Simioni, Paolo
    Bombonato, Giancarlo
    Burra, Patrizia
    Angeli, Paolo
    AMERICAN JOURNAL OF MEDICINE, 2021, 134 (10): : 1278 - +
  • [40] Combination of Traditional Chinese Medicine and Low-Molecular-Weight Heparin Prevents Deep Vein Thrombosis After Surgery: A Meta-Analysis
    Chen, Chu
    Tang, Qing
    Zhang, Wenjuan
    Yuan, Huijun
    Huai, Ying
    Jiang, Kai
    Wu, Yilun
    Zhao, Heping
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25